[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334788-105":59,"doc-detail-334788-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","comprehensive-inherited-risk-estimation-for-risk-based-breast-cancer-screening-in-women","Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women","","Family history and pathogenic variants guide risk surveillance for selected high-risk women, yet their population-level impact on breast cancer screening remains unclear. Polygenic risk scores (PRSs) can stratify risk by aggregating common genetic variants. Longitudinal real-life data from FinnGen linked to nationwide biennial screening (1992–2019) evaluates PRS, family history, and susceptibility gene PVs for risk-stratified screening.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-inherited-risk-estimation-for-risk-based-breast-cancer-screening-in-women/334788/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-inherited-risk-estimation-for-risk-based-breast-cancer-screening-in-women/334788.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study purpose regarding inherited risk factors in breast cancer screening?","Question",{"text":113,"@type":114},"To determine how family history and pathogenic variants, and especially polygenic risk scores, affect risk-stratified breast cancer screening at the population level.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were PRS, family history, and pathogenic variants evaluated in the study?",{"text":118,"@type":114},"Using longitudinal real-life data from FinnGen linked to the Mass Screening Registry for breast cancer (1992–2019), assessing screening performance for risk stratification.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find about a high polygenic risk score?",{"text":122,"@type":114},"Women with a high PRS were more likely to be diagnosed after a positive screening finding, showed elevated interval breast cancer risk, and combinations of risk factors increased positive predictive values.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334788,1790160555,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Original Reports | Breast Cancer  \nComprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women  \nNina Mars, MD, PhD1,2  ;SiniKerminen, PhD1  ;Max Tamlander, MD1  ;Matti Pirinen, PhD1,3,4;Eveliina Jakkula, MD, PhD5,6  ;KirsimariAaltonen, MD, PhD5,6; Tuomo Meretoja, MD, PhD7,8; Sirpa Heinvaara, PhD4,9  ; Elisabeth Widn, MD, PhD1  ; and Samuli Ripatti, PhD1,2,4  ; on behalf of FinnGen  \nDOI [https://doi.org/10.1200/JCO.23.00295](https://doi.org/10.1200/JCO.23.00295)  \n\n| ABSTRACT |  |\n| --- | --- |\n| PURPOSE | Family history (FH) and pathogenic variants (PVs) are used for guiding risk surveillance in selected high-risk women but little is known about their impact for breast cancer screening on population level. In addition, polygenic risk scores (PRSs) have been shown to efﬁciently stratify breast cancer risk through combining information about common genetic factors into one measure. |\n| METHODS | In longitudinal real-life data, we evaluate PRS, FH, and PVs for stratiﬁed screening. Using FinnGen (N 5 117,252), linked to the Mass Screening Registry for breast cancer (1992-2019; nationwide organized biennial screening for age 50-69 years), we assessed the screening performance of abreast cancer PRSand compared its performance with FH of breast cancer and PVs in moderate-(CHEK2) -to high-risk (PALB2) susceptibility genes. |\n| RESULTS | Effect sizes for FH, PVs, and high PRS (>90th percentile) were comparable in screening-aged women, with similar implications for shifting age at screening onset. A high PRS identiﬁed women more likely to be diagnosed with breast cancer after a positive screening ﬁnding (positive predictive value [PPV], 39.5%[95% CI, 37.6 to 41.5]) . Combinations of risk factors increased the PPVs up to 45% to 50% . A high PRS conferred an elevated risk of interval breast cancer (hazard ratio [HR], 2.78 [95% CI, 2.00 to 3.86] at age 50 years; HR, 2.48 [95% CI, 1.67 to 3.70] at age 60 years), and women with a low PRS (\u003C10th percentile) had a low risk for both interval-and screen-detected breast cancers. |\n| CONCLUSION | Using real-life screening data, this study demonstrates the effectiveness of abreast cancer PRS for risk stratiﬁcation, alone and combined with FH and PVs. Further research is required to evaluate their impact in a prospective riskstratiﬁed screening program, including cost-effectiveness. |\n\nACCOMPANYING CONTENT  \n Editorial, p. 1462  Appendix  \n Data Supplement  \nAccepted December 20, 2023 Published February 29, 2024  \nJ Clin Oncol 42:1477-1487 © 2024 by American Society of Clinical Oncology  \nView Online Article  \nCreative Commons Attribution Non-Commercial No Derivatives 4.0 License  \nINTRODUCTION  \nOrganized population-based screening has a prominent role in early detection of breast cancer in many countries, and reduction of breast cancer mortality has followed adoption of such screening programmes.1 ,2 Yet, the programs have also generated much controversy around the balance of beneﬁtsand harms, particularly regarding the age of initiation and screening interval. Instead of the one-size-ﬁts-all regimen, increasing evidence suggests that cost-efﬁciency and the beneﬁt-harm balance could be improved by risk-tailored screening, giving the opportunity to personalize the start and stop ages, and the screening interval.3 Such risk-tailored surveillance has long been used for speciﬁc subgroups, such as carriers of pathogenic variants (PVs) in moderate-or high-risk breast cancer susceptibility genes (eg, BRCA1 and PALB2), and with accumulation of early-onset breast cancer in the family.4 ,5  \nIn addition to moderate-and high-risk variants in susceptibility genes, breast cancer has a polygenic inheritance where many common variants across the genome jointly contribute to disease risk. Polygenic risk scores (PRS) combine such information into a single metric of inherited disease susceptibility.6 Compared with individuals with an average breast cancer PRS, a high PRS confers an up ","cbCaicR6jiR7uawz","https://ap.wps.com/l/cbCaicR6jiR7uawz","pdf",1184404,22,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Context\n## Key Objective\n## Knowledge Generated\n## Relevance","[{\"question\":\"What was the study purpose regarding inherited risk factors in breast cancer screening?\",\"answer\":\"To determine how family history and pathogenic variants, and especially polygenic risk scores, affect risk-stratified breast cancer screening at the population level.\"},{\"question\":\"How were PRS, family history, and pathogenic variants evaluated in the study?\",\"answer\":\"Using longitudinal real-life data from FinnGen linked to the Mass Screening Registry for breast cancer (1992–2019), assessing screening performance for risk stratification.\"},{\"question\":\"What did the study find about a high polygenic risk score?\",\"answer\":\"Women with a high PRS were more likely to be diagnosed after a positive screening finding, showed elevated interval breast cancer risk, and combinations of risk factors increased positive predictive values.\"}]","Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women | PDF",1790008381,55]